These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3202609)

  • 21. [Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma].
    Werner W; Smesny S; Schubert J
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):519-27. PubMed ID: 10996943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of superficial tumors of the bladder].
    Patard JJ; Chopin D; Abbou CC
    Cancer Radiother; 1998 Apr; 2 Suppl 1():19s-26s. PubMed ID: 9749073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.
    Shipley WU; Kaufman DS; Heney NM; Althausen AF; Zietman AL
    J Urol; 1999 Aug; 162(2):445-50; discussion 450-1. PubMed ID: 10411054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of doxorubicin in human bladder tumors.
    Gan Y; Wientjes MG; Badalament RA; Au JL
    Clin Cancer Res; 1996 Aug; 2(8):1275-83. PubMed ID: 9816297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail?
    Liedberg F; Anderson H; Chebil G; Gudjonsson S; Höglund M; Lindgren D; Lundberg LM; Lövgren K; Fernö M; Månsson W
    Urol Oncol; 2008; 26(1):17-24. PubMed ID: 18190825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Indications and results of treatments of bladder tumors].
    Le Duc A
    Rev Prat; 1997 Feb; 47(4):379-81. PubMed ID: 9114522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodology of superficial bladder cancer trials: objective evaluation of treatment - the need for standardization.
    Bassi PF; Volpe A; Racioppi M; D'Agostino D; Gardi M; Totaro A; Pinto F; Sacco E; Bongiovanni L
    Urol Int; 2009; 83(3):258-63. PubMed ID: 19829021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
    Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
    Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
    Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
    Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.
    Clairotte A; Lascombe I; Fauconnet S; Mauny F; Félix S; Algros MP; Bittard H; Kantelip B
    Am J Clin Pathol; 2006 Jan; 125(1):119-26. PubMed ID: 16483000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What's new in 2008 in the field of basic and clinical research in bladder cancer?].
    Phé V; Rouprêt M; Irani J
    Prog Urol; 2009 May; 19 Suppl 2():S43-50. PubMed ID: 19447328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors.
    Lascombe I; Clairotte A; Fauconnet S; Bernardini S; Wallerand H; Kantelip B; Bittard H
    Clin Cancer Res; 2006 May; 12(9):2780-7. PubMed ID: 16675571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and therapy of superficial tumors of the urinary bladder].
    Babjuk M; Dvorácek J
    Cas Lek Cesk; 2002 Nov; 141(23):723-8. PubMed ID: 12650028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.